Oxetanes
![eMolecules Pharmablock / (2S)-oxetane-2-carboxylic acid / 25mg / 592923358 / PBZ0840 / 0.000 / 2241107-29-7 / [null] / 102.089 / C4H6O3](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502447794.PNG-250.jpg)
eMolecules Pharmablock / (2S)-oxetane-2-carboxylic acid / 25mg / 592923358 / PBZ0840 / 0.000 / 2241107-29-7 / [null] / 102.089 / C4H6O3
Pharmablock / (2S)-oxetane-2-carboxylic acid / 25mg / 592923358 / PBZ0840 / 0.000 / 2241107-29-7 / [null] / 102.089 / C4H6O3
eMolecules Ambeed (S)-Oxetane-2-carboxylic acid 250mg 761013351 A542629 0 000 2241107-29-7 102 089 C4H6O3
Ambeed (S)-Oxetane-2-carboxylic acid 250mg 761013351 A542629 0 000 2241107-29-7 102 089 C4H6O3
Chemscene ChemScene | 3-Bromooxetane | 25G | CS-D1251 | 0.98 | 39267-79-3| MFCD08544402 | 136.98
ChemScene | 3-Bromooxetane | 25G | CS-D1251 | 0.98 | 39267-79-3| MFCD08544402 | 136.98
Frontier Specialty Chemicals 5G 3-IODOOXETANE
This item has a minimum qty of 3 per supplier requirements.
3-Iodooxetane; CAS: 26272-85-5 ; 5g
Medchemexpress LLC Typhaneoside | 104472-68-6 | 770.69 | 5 MG
Typhaneoside | 104472-68-6 | 770.69 | 5 MG
Medchemexpress LLC RBN-3143 | 2360853-16-1 | C22H28FN3O4S | 100 MG
RBN-3143 is a potent and selective inhibitor targeting PARP14, exhibiting an IC50 value of 4 nM. This compound effectively inhibits PARP14-mediated ADP-ribosylation and helps stabilize PARP14 in cellular models. It has shown promise in preclinical studies related to lung inflammation.
- Potent and NAD+-competitive PARP14 inhibitor.
- Demonstrates an IC50 of 4 nM against PARP14.
- Inhibits ADP-ribosylation activity of PARP14.
- Stabilizes PARP14 in cell lines.
- Investigated for its potential in lung inflammation research.
Medchemexpress LLC RBN-3143 | 2360853-16-1 | C22H28FN3O4S | 1 ML
RBN-3143 is a potent and NAD+-competitive catalytic PARP14 inhibitor with an IC50 value of 4 nM. It inhibits PARP14-mediated ADP-ribosylation and stabilizes PARP14 in cell lines. RBN-3143 can be used in research of lung inflammation.
- Potent and NAD+-competitive catalytic PARP14 inhibitor.
- Inhibits PARP14-mediated ADP-ribosylation and stabilizes PARP14 in cell lines.
- Can be used in research of lung inflammation.
- In vivo, RBN-3143 (5 μg; intranasal administration) can improve steroid-resistant asthma mouse models.
- Suppressed the accumulation of alarmins TSLP, IL-33, and IL-25.
![Advanced Chemblocks Inc 2-Oxa-6-aza-spiro[3.3]heptane; 1G; 97%](https://assets.fishersci.com/TFS-Assets/CCG/product-images/VN00120763-A-799.PNG-250.jpg)
Advanced Chemblocks Inc 2-Oxa-6-aza-spiro[3.3]heptane; 1G; 97%
Chemical Name: 2-Oxa-6-aza-spiro[3.3]heptane CAS: 174-78-7 MW: 99.13 MDL Number: MFCD12407093 Category: spiro Synonym: 2-Oxa-6-aza-spiro[3.3]heptane
eMolecules tert-Butyl 4-(allyloxy)piperidine-1-carboxylate | 163210-43-3 | MFCD09261170 | 1g
Ambeed | tert-Butyl 4-(allyloxy)piperidine-1-carboxylate | 1g | 600829894 | A1352105 | | 163210-43-3 | MFCD09261170 | 241.331 | C13H23NO3
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool
eMolecules Synthonix 2-Oxetanecarboxylic acid 100mg 672554382 X6939 0 000 864373-47-7 MFCD08544406 102 089 C4H6O3
Synthonix 2-Oxetanecarboxylic acid 100mg 672554382 X6939 0 000 864373-47-7 MFCD08544406 102 089 C4H6O3
eMolecules Advanced ChemBlocks Oxetane-2-carboxylic acid 250mg 199465714 D-2702 97 000 864373-47-7 MFCD08544406 102 089 C4H6O3
Advanced ChemBlocks Oxetane-2-carboxylic acid 250mg 199465714 D-2702 97 000 864373-47-7 MFCD08544406 102 089 C4H6O3
eMolecules Synthonix 2-Oxetanecarboxylic acid 250mg 138797434 X6939 0 000 864373-47-7 MFCD08544406 102 089 C4H6O3
Synthonix 2-Oxetanecarboxylic acid 250mg 138797434 X6939 0 000 864373-47-7 MFCD08544406 102 089 C4H6O3